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Purpose: Misfolding mutations in rod opsin are a major cause of the inherited blindness retinitis pigmentosa. Therefore,
understanding the role of molecular chaperones in facilitating rod opsin biogenesis and the response to mutant rod opsin
is important for retinal disease and fundamental retinal cell biology. A recent report has shown that Drosophila rhodopsin
Rh1 requires calnexin (Cnx) for its maturation and correct localization to R1–6 rhabdomeres. In this report, we investigate
the role of Cnx in the processing of wild-type and mutant mammalian rod opsin.
Methods: Mouse embryonic fibroblasts (MEFs) from control mice (WT) and mice that express a truncated dysfunctional
version of Cnx (sCnx) were used to assess the role of Cnx in the biogenesis, maturation, degradation, and aggregation of
mutant and wild-type rod opsin. The mutant P23H rod opsin was used as a prototypical class II misfolding mutant as it is
retained in the endoplasmic reticulum (ER) and is either degraded by ER associated degradation (ERAD) or forms
aggregates that coalesce to form intracellular inclusions.
Results: Wild-type rod opsin protein translocated normally to the plasma membrane in both cell lines. In contrast, P23H
rod opsin was retained in the ER in both cell lines. The only difference observed in rod opsin processing between the WT
and sCnx MEFs was a small increase in the incidence of P23H intracellular inclusions in the sCnx cells. This did not
appear to be specific for rod opsin, however, as non-rod opsin-expressing sCnx cells also had an increased incidence of
ubiquitylated inclusions.
Conclusions: Our data show that, unlike Drosophila Rh1, mammalian rod opsin biogenesis does not appear to have an
absolute requirement for Cnx. Other chaperones are likely to be more important for mammalian rod opsin biogenesis and
quality control.
Rhodopsin, a seven transmembrane domain protein, is a
prototypic  member  of  the  G-protein  coupled  receptors
(GPCRs) and was the first in this diverse family of proteins to
have its crystal structure elucidated [1]. Rhodopsin is formed
from the rod opsin protein and the chromophore 11-cis-retinal.
Mutations in rod opsin were first described in 1990 [2] and
are the most common cause of autosomal dominant retinitis
pigmentosa  (ADRP;  OMIM  180380).  Over  120  point
mutations in rod opsin have now been identified (Retnet).
Heterologous  expression  of  rod  opsin  in  mammalian  cell
culture  and  transgenic  animal  studies  have  been  used  to
characterize many of these mutations [3–11]. These studies
have revealed two major classes of rod opsin mutations [12].
Class I mutants at the C-terminus of the protein fold normally
but are not correctly targeted to the outer segment, whereas
class II mutants in the intradiscal and transmembrane domains
cause  protein  misfolding,  resulting  in  retention  in  the
endoplasmic reticulum (ER), degradation, and aggregation.
Therefore, it is important to investigate the biogenesis, quality
control, and degradation of normal and mutant rod opsin to
design therapies for ADRP and enhance our understanding of
GPCR biology.
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The  biogenesis  and  quality  control  of  multispanning
membrane proteins like rod opsin occurs at the ER. Certain
steps  in  this  pathway  and  the  potential  involvement  of
molecular chaperones have been discussed elsewhere [13].
The highlights of this process include binding of the rod opsin
signal  sequence  to  the  signal  recognition  particle  [14]
directing the ribosome and the growing polypeptide to the ER
membrane. This signal sequence is not cleaved [15], and opsin
inserts in the ER cotranslationally [16].
Upon insertion into the ER membrane the N-terminal
intradiscal domain of mammalian rod opsin is N-glycosylated
at Asn2 and Asn15 by the oligosaccharyl transferase enzyme
[17]. Most glycoproteins use their glycan chains for correct
folding and oligomeric assembly [18,19]; however, inhibition
of glycosylation by tunicamycin suggests mammalian rod
opsin does not require glycan chains for correct folding [6,
10]. Furthermore, an intact carbohydrate unit for mammalian
rod opsin is not essential for its chromophoric properties or
for its regeneration [20]. In contrast, the class II rod opsin
mutant P23H requires glycan chains for efficient degradation
via endoplasmic reticulum associated degradation (ERAD).
Mutant rod opsin accumulation in the ER, observed upon
tunicamycin treatment, has revealed a glycan independent
quality control mechanism that prevents the mutant protein
from escaping the ER [10].
Glycan chains render nascent glycoproteins substrates for
resident lectin chaperones of the ER, most notably calnexin
(Cnx) and calreticulin [21–23]. This quality control process
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2466ensures that only correctly folded, assembled, and modified
proteins are transported along the secretory pathway and is a
paradigm of protein folding in the ER that includes other
folding  facilitators  such  as  ERp57,  which  associates  with
lectin  chaperones  Cnx  and  calreticulin  to  catalyze
glycoprotein  disulphide  formation/isomerization  [24].  The
membrane  association  of  a  nascent  glycoprotein  will
determine whether it will associate with Cnx, calreticulin, or
both [25].
Cnx  holds  a  central  role  in  the  folding  of  many
glycoproteins in the ER [22,23,26]. Elegant genetic studies
performed with the Drosophila homolog of mammalian rod
opsin,  Rh1,  have  revealed  a  requirement  for  Cnx  in  its
maturation [27]. Mutations in Drosophila Cnx led to severe
defects in Rh1 expression, whereas other photoreceptor cell
proteins  were  expressed  normally,  suggesting  a  specific
requirement by Rh1 for this lectin chaperone [27]. Drosophila
Rh1 has two putative N-glycosylation sites at Asn20 and Asn196
[28] found on the extracellular domain of the protein [29].
Site-directed  mutagenesis  of  these  residues  led  to  the
accumulation  of  Rh1  protein  within  the  ER  and  retinal
degeneration [28–30]. Therefore, there appears to be clear
differences between Rh1 and mammalian rod opsin in the
requirement for glycosylation during processing. In this study
we have investigated if these differences are reflected by a
divergence in the need for Cnx in rod opsin biogenesis.
Mice congenitally deficient in the expression of the Cnx
gene have been previously produced and phenotyped [31].
The homozygous Cnx-deficient embryos were carried to full
term; however, about 50% died within 2 days after birth and
the remainder developed severe motor disorders which led to
premature death. A second Cnx-deficient mouse strain was
generated  by  an  unexpected  recombination  event,  which
expressed a truncated Cnx protein (sCnx) resulting from the
deletion of a selectable marker [31]. The truncated Cnx gene
had lost exons 4, 5, and 6, and the protein product was about
15 kDa smaller than the full-length Cnx protein. The deleted
region included cysteine residues involved in disulphide bond
formation and residues that form the glucose bonding pocket,
for  binding  of  monoglucosylated  glycoproteins.
Unfortunately, the retina was not included in the phenotyping
of the Cnx null or sCnx mice, and these animals are no longer
available for study. Mouse embryonic fibroblasts (MEFs),
derived  from  wild-type  (WT)  and  sCnx  mice  have  been
characterized [32]. Replacement of Cnx with sCnx did not
affect cell viability or trigger a compensatory upregulation of
other ER-resident chaperones such as BiP, PDI, ERp57 or Crt
[32]. Importantly, unlike Cnx, sCnx did not associate with
newly synthesized glycoproteins; hence, even though sCnx is
not a null mutation, and encodes a protein that still targets to
the  ER,  it  shows  loss  of  its  affinity  for  glycoproteins,
endogenous and transfected, compared to WT MEFs.
Therefore, we used MEFs derived from WT and sCnx
mice to test if Cnx was necessary for the biogenesis and
maturation of mammalian rod opsin, as it is for Drosophila
Rh1. The data show that mammalian rod opsin does not appear
to require Cnx for normal processing through the secretory
pathway or quality control and degradation of mutant rod
opsin, but sCnx cells do appear to have general problems with
metastable protein folding.
METHODS
WT and sCnx MEFs were a gift of M. Molinari (Institute for
Research  in  Biomedicine,  Bellinzona,  Switzerland).
Lipofectamine and Plus reagent were purchased from Life
Technologies (Paisley, UK). 4',6-diamidino-2-phenylindole
(DAPI) for nuclear staining, and Protease Inhibitor Cocktail
in Dimethyl Sulfoxide (DMSO) for mammalian cell extracts
were  purchased  from  Sigma  (Dorset,  UK).  The  primary
antibodies used were mAb 1D4 to rod opsin, which was a gift
from R. Molday (University of British Columbia, Vancouver,
Canada). Mouse monoclonal anti-myc antibody (9E10) was
from Sigma. Rabbit polyclonal anti-Cnx (SPA-860) was from
StressGen  Biotechnologies  (Cambridge,  UK).  Goat
antimouse antibodies conjugated to horseradish peroxidase
were  from  Pierce  (Northumberland,  UK).  Antimouse
secondary Cy3 conjugated secondaries were from Jackson
Immunoresearch (Suffolk, UK). The BCA protein assay kit
was from Pierce. Bovine wild-type (WT) rod opsin in pMT3
were gifts from D. Oprian (Brandeis University, Waltham,
MA). P23H rod opsin in pMT3 was prepared by site-directed
mutagenesis using WT pMT3 as a template. WT and P23H
constructs were cloned into EcoRI/NotI sites of pMT3 vector
and into BamHI/AgeI sites of pEGFP-N1, in frame with GFP,
such that the GFP sequence was fused to the C-terminus of
rod opsin [10]. His6-myc-tagged ubiquitin plasmid was a gift
from  R.  Kopito  (Stanford  University,  Stanford,  CA).
pEGFPC1 (Clontech, St-Germain-en-Laye, France) was used
as a GFP control.
Cell culture, transfection, and scoring: WT and sCnx
MEFs were grown in DMEM/F12 with Glutamax-I+10% (v/
v) heat-inactivated fetal bovine serum (FBS) and 1% (v/v)
penicillin/streptomycin with an atmosphere of 5% (v/v) CO2
at 37 °C. Glass coverslips were treated with Alcian blue dye
and were placed in 24 well plates. Glass coverslips were
seeded with 5x104 cells per well; 24 h after seeding, the cells
were transfected with 0.75 μg DNA per well, with 4 μl Plus,
and  2  μl  Lipofectamine  Plus  is  a  proprietary  name  for  a
transfection reagent provided by Life Technologies (Paisley,
UK). Next, 24 h after transfection, cells were washed with
phosphate  buffered  saline  (PBS,  Oxoid;  137  mM  sodium
chloride,  2.7  mM  potassium  chloride,  8.1  mM  disodium
hydrogen  phosphate,  1.5  mM  potassium  dihydrogen
phosphate) and were fixed with 4% (v/v) paraformaldehyde
(PFA) for 15 min. The slides were mounted with fluorescent
mounting  medium  (DAKO,  Cambridgeshire,  UK).
Transfection  efficiency  was  determined  from  four
independent experiments by scoring the number of rod opsin-
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the total cells. For morphological analyses, five groups of
approximately 100 transfected cells each were counted using
a Leica DM RBE Fluorescent microscope in four separate
experiments. The distribution of WT opsin-GFP and P23H
opsin-GFP  in  transfected  cells  was  classified  either  as
predominantly plasma membrane, predominantly ER or as
containing  inclusions.  Counts  were  analyzed  using  the
ANOVA test (ANOVAR), used to compare the means of two
samples. Images were collected with a Zeiss LSM 510 laser
scanning  confocal  microscope  (Welwyn  Garden  City,
Hertfordshire, UK). The excitation/emission spectrum used
for  GFP  was  488/507.  Images  were  exported  from  LSM
browser  to  Adobe  Photoshop  for  figure  preparation  and
annotation in Adobe Illustrator (San Jose, CA).
Immunocytochemistry:  Twenty-four  hours  after
transfection, cells were incubated in 3% (v/v) PFA at 37 °C
for  10  min  and  transferred  to  0.5%  (v/v)  PFA  at  room
temperature  for  20  min.  Cells  were  incubated  in  50  mM
NH4Cl  for  5  min  on  ice  and  transferred  to  PBS  at  room
temperature. Triton X-100 was added at a concentration of
0.5% (v/v) in PBS for 10 min. The slides were washed twice
with PBS and blocked for 1 h with PBS containing 10% (v/v)
FBS and 10% (v/v) normal donkey serum. Anti-myc (Sigma)
antibody (1:1,000) or anti-Cnx (StressGen; 1:600) primary
antibody in blocking buffer were added for 1 h. The slides
were then washed twice in PBS and donkey antimouse Cy3
(Jackson Immunoresearch) was used at 1:100 in blocking
buffer for 1 h. Cells were washed twice with PBS and once
with  DAPI  at  a  concentration  of  2  μg/ml  in  PBS  before
mounting  in  fluorescent  mounting  medium  (DAKO).
Fluorescence was observed on a Carl Zeiss LSM 510 confocal
laser  scanning  microscope  for  image  acquisition.  The
excitation/ emission spectrum used for Cy3 was 543/570 nm.
Images  were  exported  from  LSM  browser  to  Adobe
Photoshop for figure preparation and annotation in Adobe
Illustrator.
Preparation  of  cell  extracts:  For  35  mm  dishes,  the
transfection mix containing untagged rod opsin in the pMT3
vector was scaled up 5 times and cells were transfected 24 h
after seeding with 4×105 cells per well. Cells were washed
twice in ice-cold PBS and incubated in 200 μl PBS/1% n-
Dodecyl-β-D-Maltoside  (DM)  with  1%  protease  inhibitor
cocktail. Cell lysates were centrifuged at 17,500x g for 10 min
at 4 °C. Cell fractions were normalized for total protein using
the BCA Protein Assay Kit (Pierce) and read with a Safire
fluorescence plate reader (Tecan, Ltd., Reading, UK). For
SDS–PAGE  a  volume  of  5X  modified  (30%  glycerol)
Laemmli sample buffer was added to the soluble fraction. The
proteins were resolved on 10% SDS–PAGE gels and were
semidry electroblotted (BioRad) onto Protran nitrocellulose
membrane  (Schleicher  &  Schuell  BioScience,  Dassel,
Germany). For immunodetection of rod opsin, mAb 1D4 was
used at a concentration of 1.33 μg/ml, for GFP anti-av peptide
sera (Clontech) was used at 1:2,000, and goat anti-mouse HRP
(Pierce)  was  used  at  1:30,000  in  PBS+1%  (w/v)  Marvel
(Premier  Brands),  0.1%  (v/v)  Tween-20.  The
chemiluminescent detection reagent ECL Plus (Amersham
Pharmacia Biotech, Little Chalfont, UK) was used to detect
immobilized  antigens  according  to  the  manufacturer’s
instructions.
RESULTS
Characterization of sCnx cells: The localization of Cnx in the
control  WT  and  sCnx  MEFs  was  investigated  by
immunocytochemistry. As previously reported [32], both Cnx
and sCnx localized to the ER (Figure 1A,B). Importantly, the
Cnx immunofluorescence signal for the sCnx cells was lower
than for WT cells. Western blotting of detergent extracts of
WT and sCnx MEFs confirmed the expression of the truncated
Cnx protein in the sCnx cells (Figure 1C). The sCnx protein
gives rise to a protein about 15 kDa smaller than the full length
Cnx  protein.  sCnx  was  present  at  lower  levels  than  Cnx.
Western blotting for BiP confirmed previous data [32] that a
compensatory upregulation of other ER resident chaperones
had not taken place.
Wild-type opsin translocates to the plasma membrane in sCnx
cells: Rod opsin expression has been investigated in a range
of cultured cell types. It has been well documented that WT
rod opsin translocates to the plasma membrane in the absence
of an outer segment [3,6,10]. The localization of WT rod opsin
Figure 1. Cnx expression in control and sCnx cells. A: Localization
of  calnexin  (Cnx)  protein  in  wild-type  (WT)  mouse  embryonic
fibroblasts (MEFs). B: Short Cnx localization in sCnx cells. The
truncated protein shows the same staining pattern, as it still contains
the N-terminal endoplasmic reticulum (ER)-targeting sequence and
the  C-terminal  ER  retention  motif  of  full-length  Cnx.  Note  the
intensity of the sCnx staining was lower and has been adjusted to
reveal the pattern. Scale bar equals 10 μm. C: Expression of ER
resident chaperones Cnx and BiP in WT and sCnx cells. Western blot
revealed  reduced  expression  level  and  increased  electrophoretic
mobility of the truncated Cnx protein from sCnx cells and similar
BiP levels in both cell lines.
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2468was investigated in WT and sCnx MEFs (Figure 2). WT and
sCnx MEFs were transfected with WT rod opsin fused to GFP
at the C-terminus (WT-GFP). The localization of rod opsin
was investigated by confocal immunofluorescence using the
intrinsic GFP fluorescence. In both cell types WT rod opsin
was processed to the plasma membrane with no retention in
the ER, indicating that the protein had progressed through the
secretory  pathway  (Figure  2A,B).  There  was  no
morphological difference in the localization of opsin between
the two cell lines, hence Cnx appeared to be dispensable for
the correct processing of WT opsin in MEFs. DM detergent
soluble cell extracts from WT and sCnx cells transfected with
untagged WT rod opsin were analyzed by western blotting and
revealed  no  difference  in  the  1D4  immunoreactive  band
pattern (Figure 2C). This confirmed similar processing and
glycosylation in WT and sCnx cells. The expression level of
WT rod opsin in the sCnx cells, however, was variable and
generally lower than in the WT MEFs at equivalent total
protein loadings. This corresponded with lower transfection
efficiency in the sCnx cells; for example, the transfection
efficiency  for  WT-GFP  determined  from  4  independent
experiments was 27%±11 for the sCnx compared to 44%±22
for the WT MEFs. This did not appear to be rod opsin-specific
as similar trends were observed for GFP alone. EndoH and
PNGase F digestion of WT rod opsin in soluble cell lysates
did not reveal any differences between the WT and sCnx
MEFs (data not shown). To test if Cnx may influence the
degradation and aggregation of WT rod opsin, WT, and sCnx
MEFs were scored for incidence of inclusion formation of
WT-GFP. No increase in the small percentage of cells that
form WT-GFP inclusions (approximately 1%) was observed
in the sCnx cells (Figure 2D).
P23H  rod  opsin  localizes  in  the  ER  and  in  cytoplasmic
inclusions in WT and sCnx cells: P23H rod opsin has been
shown to be retained in the ER before retrotranslocation and
degradation by the ubiquitin proteasome system (UPS). If it
is not degraded, the misfolded rod opsin can aggregate and is
sequestered  into  cytoplasmic  inclusion  bodies,  resembling
aggresomes  [9,10].  Similarly  here,  P23H  rod  opsin-GFP
(P23H-GFP)  expressed  in  both  WT  and  sCnx  MEF
accumulated in the ER and formed intracellular inclusion
bodies (Figure 3A,B). Western analysis revealed the same
band  pattern  for  DM  soluble  untagged  P23H  rod  opsin
expressed in both WT and sCnx cells (Figure 3C). EndoH and
PNGase F digestion of P23H rod opsin from soluble cell
lysates did not reveal any differences between the WT and
sCnx MEFs (data not shown). Similar to WT rod opsin, the
expression level of P23H rod opsin in the sCnx cells was
generally lower than in WT MEFs, corresponding to a lower
transfection efficiency (45%±6 for WT MEFs and 28%±13
for sCnx). Rod opsin localization cell counts were generated
from 5 fields of roughly 100 cells each. These were scored for
ER staining or inclusion formation. Approximately 22% of
P23H-GFP  expressing  sCnx  MEFs  contained  at  least  1
inclusion  after  24  h,  whereas  only  11%  of  P23H-GFP
expressing WT MEFs had inclusions at this time (p<0.05)
(Figure 3D). This difference may be attributed to the sCnx
being unable to process the mutant misfolded P23H opsin as
well as the WT cells, but could reflect global protein folding
problems in the sCnx cells.
Enhanced inclusion formation of metastable proteins in sCnx
cells: To test if the enhanced aggregation observed for P23H
rod opsin was specific for mutant rod opsin or reflected more
generalized problems of protein folding, we examined the
ubiquitin immunoreactivity in WT and sCnx MEFs. Ubiquitin
staining can be used to reveal the presence of ubiquitylated
inclusions of endogenous unidentified aggregated proteins.
WT  MEFs  transfected  with  myc-ubiquitin  had  a  diffuse
staining pattern characteristic of ubiquitin (Figure 4A). In
Figure 2. Wild-type rod opsin expression in control and sCnx cells.
Wild-type (WT) rod opsin-green fluorescent protein (GFP; WT-
GFP) translocates to the plasma membrane of WT (A) and calnexin
(sCnx) cells (B). Scale bar equals 10 μm. C: western blotting of
untagged rod opsin with mAb 1D4 of 15 μg of soluble protein from
WT or sCnx cell lysates (as indicated) revealed no difference in
immunoreactive opsin band pattern. This representative blot was
selected because of the similar rod opsin expression level between
WT and sCnx cells to better demonstrate similar band pattern. The
position of molecular weight markers in kDa are indicated on the left.
D:  Quantification  of  inclusion  incidence  for  WT-opsin-GFP
expressing cells after 24 h revealed no significant difference in WT-
opsin-GFP aggregation in sCnx cells. Five groups of greater than 100
cells expressing WT-opsin-GFP opsin were scored for the presence
of  inclusions  (the  remaining  cells  had  predominantly  plasma
membrane staining). Error bars represent ±2 Standard Error (SEM).
Statistical  analysis  was  performed  by  ANOVAR  followed  by
posthoc tests. The asterisk indicates p<0.05.
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2469contrast, a punctate staining pattern characteristic of multiple
intracellular  inclusions  positive  for  myc-ubiquitin  was
revealed  upon  expression  in  sCnx  MEFs,  indicating  their
enhanced stress susceptibility in the folding of endogenous
polypeptides (Figure 4B). WT and sCnx MEFs were scored
for  the  presence  of  these  inclusions  in  3  independent
experiments.  WT  cells  had  at  least  one  inclusion  in  14%
(Figure 4C) of transfected cells while the sCnx MEFs had
inclusions in 55% (Figure 4C) of cells (p<0.05). The presence
of an aggregation-prone metastable protein in the sCnx cells
could be predicted to result in enhanced aggregation because
of reduced chaperone activity within these cells. Hence, we
expressed P23H rod opsin-GFP with the myc-tagged ubiquitin
and scored cells with ubiquitylated inclusions. In the presence
Figure 3. P23H rod opsin expression in WT and sCnx cells. P23H-
GFP opsin is retained in the endoplasmic reticulum (ER) and forms
intracellular inclusions (arrowed in the inset panel) in wild-type
(WT; A) and sCnx mouse embryonic fibroblasts (MEFs; B). Scale
bar equals 10 μm. C: western blotting of untagged P23H rod opsin
with  mAb  1D4  of  15  μg  of  soluble  protein  revealed  the  same
glycoform pattern of expression for P23H opsin in WT or sCnx cell
lysates (as indicated). This representative blot has been selected for
similar rod opsin expression level. The position of molecular weight
markers in kDa are indicated on the left. D: The incidence of P23H
inclusion formation in WT and sCnx MEFs was quantified. Cells
were transfected with P23H-opsin-green fluorescent protein (GFP),
and the percentages of transfected cells with intracellular inclusions
after 24 h were scored blind to experimental status (the noninclusion
positive cells had predominant ER staining). Five groups of greater
than  100  cells  expressing  GFP  opsin  were  counted.  Error  bars
represent  ±2  SEM.  Statistical  analysis  was  performed  using
ANOVAR followed by posthoc tests. The asterisk indicates p<0.05.
of  P23H-GFP,  the  number  of  ubiquitylated  inclusions
increased for both WT and sCnx (Figure 4D). The WT cells
had at least 1 inclusion in approximately 22% of cells (Figure
4D), whereas the sCnx MEFs had inclusions in 65% (Figure
4D) of cells (p<0.05). The presence of P23H-GFP led to a 8%
increase in inclusion incidences in the WT cells and 10%
increase  in  the  sCnx  cells  (p<0.05),  suggesting  that  the
aggregation  of  mutant  opsin  caused  further  imbalance  in
proteostasis, in agreement with previous reports that P23H rod
opsin inhibits the UPS [9].
DISCUSSION
Cnx occupies a central role in the triage of many glycoproteins
in the ER [26,33]. Cnx binding retains nascent glycoproteins
in the ER to undergo cycles of folding until correct folding is
complete and the protein can exit the ER. If Cnx binding is
prolonged, then ERAD may be initiated. As Drosophila Rh1
has a requirement for Cnx in its maturation [27], we tested the
Figure 4. sCnx cells have increased ubiquitylated inclusions. Wild-
type (WT; A) and calnexin (sCnx; B) cells were transfected with a
His6-myc-tagged ubiquitin expression plasmid and were stained with
anti-myc antibody 24 h after transfection. Scale bar equals 10 μm. C:
Cells were scored for diffuse or punctate ubiquitin stain as exhibited
in (A) and (B). D: P23H rod opsin-green fluorescent protein (GFP)
and myc-ubiquitin double transfected cells were scored for diffuse
or punctate ubiquitin stain. Bar graphs represent an average of three
independent experiments. Error bars represent ±2 SEM. Statistical
analysis was performed using ANOVAR followed by posthoc tests.
The asterisk indicates p<0.05.
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2470involvement of Cnx in the processing of mammalian rod opsin
using  a  Cnx  functionally  deficient  cell  line.  We  did  not
observe any differences in the processing of rod opsin in WT
and sCnx MEFs. WT rod opsin translocated successfully to
the plasma membrane of both cell lines; P23H rod opsin was
retained in the ER and formed inclusions in WT as well as
sCnx cells. The glycoform pattern of WT and P23H rod opsin
observed by western blotting was the same in both cell lines.
The only significant difference observed was an increase in
inclusion formation for P23H rod opsin in the sCnx MEFs.
Therefore, the data clearly support the notion that Cnx is a
dispensable chaperone in the processing and ERAD of rod
opsin,  since  the  WT  and  mutant  proteins  are  processed
similarly in both cell lines, each targeting its corresponding
compartment correctly.
This  was  not  the  case  for  Drosophila  Rh1,  however,
which requires Cnx for its maturation [27]. Rh1 in WT flies
is localized solely to the rhabdomeres, whereas in Cnx mutant
flies Rh1 was detected predominantly in the ER. In a parallel
pulse-chase experiment, Rh1 in control flies had matured by
24 h whereas in Cnx mutant flies, Rh1 was initially detected
as an immature high MW form that was significantly reduced
by 24 h. After 48 h, very little Rh1 was detected, suggesting
that most of it had been degraded [27].
Drosophila  Rh1  and  mammalian  rod  opsin  appear  to
show different requirements for chaperones and chromophore
during  their  biogenesis  and  quality  control.  Rh1  was
discovered to have a requirement for NinaA [34]. Mutant
NinaAP228 flies were shown to have a severely reduced Rh1
content  in  R1–6  rhabdomeres.  Subsequently,  NinaA  was
shown  to  be  a  specific  peptidyl-prolyl-isomerase  class
chaperone  for  the  maturation  of  Rh1  [35–37].  Rh1  also
requires  3-hydroxyretinal  to  fold  correctly.  Lack  of  3-
hydroxyretinal chromophore either by dietary deprivation or
mutations in vitamin A-processing enzymes, such as NinaB
dioxygenase and NinaG oxidoreductase, leads to very low
levels  of  detectable  Rh1  in  rhabdomeres  [38].  Previous
attempts  to  express  invertebrate  visual  pigments  in
mammalian cells were not successful. For example, Limulus
opsin expressed in COS1 cells was retained within the ER,
aggregated, and did not form a functional pigment [39]. This
was probably as a result of missing factors in the COS1 cells,
such as NinaA and NinaG. These additional requirements for
Rh1 processing meant that it was not possible to directly
compare the Cnx requirement of Rh1 with mammalian rod
opsin  expression  in  sCnx  MEFs.  However,  the  reciprocal
experiment of expressing bovine rod opsin in Drosophila has
suggested that a NinaA-type chaperone for mammalian rod
opsin may not be required.
Ahmad et al. [40] showed that when bovine rod opsin was
expressed in Drosophila,it showed stable expression even in
the absence of endogenous Rh1 and chromophore and was
correctly targeted to Drosophila rhabdomeres. Unlike Rh1,
the processing of bovine rod opsin was independent of NinaA
and  NinaG  activity,  showing  a  clear  difference  in  the
processing  of  vertebrate  rod  opsin  compared  to  the
endogenous invertebrate rod opsin. The processing was not
perfect, however, as the bovine rod opsin from Drosophila
rhabdomeres exhibited only high mannose oligosaccharides
and not the fully mature Golgi forms. Also bovine rod opsin in
Drosophila  did  not  to  couple  to  Gq  although  it  could
successfully activate Gt [40].
According  to  flybase,  Drosophila  has  3  Cnx  genes,
namely CG9906, Cnx 14D, and Cnx 99A. Rosenbaum et al.
[27] identified the cytogenetic locus for the mutant phenotype
to 99A7 on Drosophila chromosome 3. This locus encodes 4
putative isoforms (A-D). Drosophila Cnx99A displays 48.3%
amino acid identity with human Cnx, whereas Drosophila
CG9906 has 50.4% amino acid identity with human Cnx.
Therefore, it is not clear which vertebrate form of Cnx would
most closely resemble Cnx99A and if this could reflect a
specialized invertebrate form of Cnx for Rh1 biogenesis and
maturation  that  is  not  conserved  across  species.  The  Cnx
family of molecular chaperones is conserved among plants,
fungi, and animals. In mammals there is one major ubiquitous
form of Cnx and a tissue-specific form, calmegin, a type-I
membrane protein expressed mainly in the spermatids of the
testis [41]. In addition to Cnx, calreticulin (Crt) is an ER
lumenal homolog. Cnx and Crt associate with a wide array of
substrates because they bind monoglucosylated N-glycans,
which are transiently exposed by glycosylated polypeptides
expressed in the ER [33]. However, Cnx and calreticulin were
found to associate with distinct sets of polypeptides in cells
[42–46]. In addition, the study by Pieren et al. [32] addressed
this specifically using WT and sCnx MEFs. The authors found
that Crt did not acquire novel substrates upon depletion of Cnx
activity.  Thus,  most  cellular  Cnx  substrates  remained
inaccessible to Crt even in the absence of Cnx activity [32].
Therefore, we would not anticipate that Crt would compensate
for the loss of Cnx activity in these cells or in the retina
[41].There  is  no  evidence,  as  yet,  for  a  mammalian  eye-
specific form of Cnx.
The increased incidence of P23H rod opsin inclusions in
sCnx cells is most likely a consequence of the enhanced stress
susceptibility  of  these  cells  [47],  and  not  to  a  specific
requirement  for  Cnx  in  P23H  rod  opsin  degradation  or
inclusion clearance. This reduced stress tolerance was also
reflected  in  the  lower  transfection  efficiency  and  protein
expression observed on transient transfection of the sCnx cells
with rod opsin or GFP. Cnx occupies a central role in the
quality control of glycoproteins either to further folding or
degradation.  The  short  nonfunctional  version  of  Cnx
expressed in sCnx cells would cause problems for the folding
of  many  nascent  glycoproteins  in  the  ER.  Therefore,  the
absence of Cnx activity could affect the stability of metastable
proteins within the cells. Alterations in proteostasis, either
from  increased  protein  misfolding  or  impaired  chaperone
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and revealing their aggregation-prone phenotype. This has
been shown to be the case in C. elegans temperature-sensitive
mutants of muscle paramyosin [48]. In this system, expression
of an aggregation-prone polyQ protein was sufficient to cause
appearance  of  the  mutant  phenotype  at  the  permissive
temperature. We observed that the sCnx cells had increased
levels  of  ubiquitylated  inclusions  both  in  the  presence  of
transfected P23H rod opsin and in its absence, suggesting that
the lack of Cnx and associated imbalance of proteostasis led
to  the  aggregation  of  metastable  proteins.  Therefore,  the
increase  in  P23H  inclusions  may  not  reflect  a  specific
requirement for Cnx, but, instead, it could be a consequence
of generalized disturbances of proteostasis in the sCnx cells.
The data highlight that vertebrate rod opsin and Rh1 are
different  opsins  with  distinct  folding  and  processing
requirements.  There  are  key  differences  not  only  in  the
mechanisms of phototransduction but also in their biogenesis,
processing, and photoreceptor organelle. While parallels can
be drawn between the two, and Drosophila has proved to be
an extremely valuable model system, the 2 opsins do not
appear to be sufficiently similar to be able to extrapolate
findings from one glycoprotein to the other. The mammalian
rod photoreceptor encloses a stack of approximately 1,000
flattened  disk  membranes  with  104–106  molecules  of
rhodopsin per disk. Daily phagocytosis of outer segments by
the  retinal  pigment  epithelium  leads  to  the  whole  outer
segment being renewed every 10 days, requiring the vectorial
delivery of millions of rhodopsin molecules each day to the
base of the outer segment. Rod opsin is synthesized in the ER
and further modified in the Golgi. Hence, it is possible that in
response  to  this  huge  demand,  rod  opsin  biogenesis  has
become finely tuned and specialized in mammalian rods by
the development of dedicated chaperone proteins. The studies
of Drosophila Rh1 have firmly established the precedent for
such  dedicated  G-protein  coupled  receptor  chaperones,
however, the specific chaperone requirements for mammalian
rod opsin remain to be identified.
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